DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Follistim (Follitropin Beta) - Drug Interactions, Contraindications, Overdosage, etc



Drug Interactions

No drug/drug interaction studies have been performed.


Aside from the possibility of Ovarian Hyperstimulation Syndrome (see WARNINGS-Overstimulation of the Ovary During Follistim® Therapy) and multiple gestations (see WARNINGS-Multiple Births), there is no additional information concerning the consequences of acute overdosage with Follistim® (follitropin beta for injection).


Follistim® (follitropin beta for injection) is contraindicated in women who exhibit:

  1. Prior hypersensitivity to recombinant hFSH products.
  2. A high circulating FSH level indicating primary ovarian failure.
  3. Uncontrolled thyroid or adrenal dysfunction.
  4. Tumor of the ovary, breast, uterus, hypothalamus or pituitary gland.
  5. Pregnancy.
  6. Heavy or irregular vaginal bleeding of undetermined origin.
  7. Ovarian cysts or enlargement not due to polycystic ovary syndrome (PCOS).


There have been no reports of abuse or dependence with Follistim® (follitropin beta for injection).

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017